![Michael Williams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Williams
Direktor/Vorstandsmitglied bei
Sarcio, Inc.
Profil
Michael Williams is currently a Board Member at Sarcio, Inc. and a Partner at PACE Healthcare Capital.
Previously, he served as a Non-Executive Director at PYC Therapeutics Ltd. in 2018 and as a Vice President at Bristol Myers Squibb Co. from 2004 to 2005.
He also held positions at Pfizer Inc. as a Vice President and at Intarcia Therapeutics, Inc. as a Chief Operating Officer.
Mr. Williams obtained his undergraduate degree from the University Of Bangor and his graduate degree in 1982 from the same institution.
Aktive Positionen von Michael Williams
| Unternehmen | Position | Beginn |
|---|---|---|
PACE Healthcare Capital
 PACE Healthcare Capital Investment ManagersFinance PACE Healthcare invests in companies located in the United States. The firm focuses on digital healthcare and healthcare technology sectors. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.25 - 2 million. | Berater | - |
Sarcio, Inc.
 Sarcio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement | Direktor/Vorstandsmitglied | 01.07.2021 |
Ehemalige bekannte Positionen von Michael Williams
| Unternehmen | Position | Ende |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 11.04.2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Private Equity Investor | 01.01.2005 |
| PFIZER INC. | Private Equity Investor | - |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Geschäftsführer | - |
Ausbildung von Michael Williams
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
35
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
University Of Bangor
 University Of Bangor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sarcio, Inc.
Sarcio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement | Commercial Services |
PACE Healthcare Capital
PACE Healthcare Capital Investment ManagersFinance PACE Healthcare invests in companies located in the United States. The firm focuses on digital healthcare and healthcare technology sectors. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.25 - 2 million. | Finance |
